Oppenheimer & CO Inc Johnson & Johnson Transaction History

Oppenheimer & CO Inc

  • $6.42 Billion
  • Q3 2024

A detailed history of Oppenheimer & CO Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Oppenheimer & CO Inc holds 179,675 shares of JNJ stock, worth $27.5 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
179,675
Previous 179,588 0.05%
Holding current value
$27.5 Million
Previous $26.2 Million 10.93%
% of portfolio
0.45%
Previous 0.42%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
BUY
$145.48 - $167.38 $12,656 - $14,562
87 Added 0.05%
179,675 $29.1 Million
Q2 2024

Aug 07, 2024
BUY
$144.38 - $157.78 $67,858 - $74,156
470 Added 0.26%
179,588 $26.2 Million
Q1 2024

May 06, 2024
SELL
$155.22 - $162.74 $1.84 Million - $1.93 Million
-11,886 Reduced 6.22%
179,118 $28.3 Million
Q4 2023

Feb 13, 2024
SELL
$145.6 - $158.88 $1.09 Million - $1.19 Million
-7,515 Reduced 3.79%
191,004 $29.9 Million
Q3 2023

Nov 07, 2023
SELL
$155.75 - $174.48 $5.06 Million - $5.67 Million
-32,508 Reduced 14.07%
198,519 $30.9 Million
Q2 2023

Aug 02, 2023
SELL
$154.35 - $166.11 $1.81 Million - $1.94 Million
-11,705 Reduced 4.82%
231,027 $38.2 Million
Q1 2023

May 10, 2023
BUY
$151.05 - $180.26 $896,632 - $1.07 Million
5,936 Added 2.51%
242,732 $37.6 Million
Q4 2022

Feb 07, 2023
SELL
$160.2 - $179.79 $10.2 Million - $11.4 Million
-63,589 Reduced 21.17%
236,796 $41.8 Million
Q3 2022

Nov 14, 2022
BUY
$161.33 - $179.52 $720,499 - $801,736
4,466 Added 1.51%
300,385 $49.1 Million
Q2 2022

Aug 08, 2022
SELL
$168.19 - $186.01 $172,394 - $190,660
-1,025 Reduced 0.35%
295,919 $52.5 Million
Q1 2022

May 12, 2022
BUY
$158.14 - $179.59 $1.4 Million - $1.59 Million
8,880 Added 3.08%
296,944 $52.6 Million
Q4 2021

Feb 02, 2022
SELL
$155.93 - $173.01 $609,530 - $676,296
-3,909 Reduced 1.34%
288,064 $49.3 Million
Q3 2021

Nov 12, 2021
SELL
$161.5 - $179.47 $145,673 - $161,881
-902 Reduced 0.31%
291,973 $47.2 Million
Q2 2021

Aug 03, 2021
BUY
$159.48 - $171.07 $461,694 - $495,247
2,895 Added 1.0%
292,875 $48.2 Million
Q1 2021

May 10, 2021
SELL
$153.07 - $170.48 $366,602 - $408,299
-2,395 Reduced 0.82%
289,980 $47.7 Million
Q4 2020

Feb 11, 2021
BUY
$137.11 - $157.38 $1.86 Million - $2.14 Million
13,598 Added 4.88%
292,375 $46 Million
Q3 2020

Nov 13, 2020
SELL
$140.38 - $153.83 $1.31 Million - $1.44 Million
-9,367 Reduced 3.25%
278,777 $41.5 Million
Q2 2020

Aug 11, 2020
BUY
$128.81 - $155.51 $1.26 Million - $1.52 Million
9,778 Added 3.51%
288,144 $40.5 Million
Q1 2020

May 08, 2020
BUY
$111.14 - $153.99 $4.78 Million - $6.63 Million
43,027 Added 18.28%
278,366 $36.5 Million
Q4 2019

Feb 07, 2020
BUY
$127.5 - $146.44 $2.22 Million - $2.55 Million
17,384 Added 7.98%
235,339 $34.3 Million
Q3 2019

Oct 31, 2019
SELL
$126.95 - $142.14 $378,818 - $424,145
-2,984 Reduced 1.35%
217,955 $28.2 Million
Q2 2019

Aug 09, 2019
SELL
$131.15 - $144.24 $3.35 Million - $3.68 Million
-25,542 Reduced 10.36%
220,939 $30.8 Million
Q1 2019

Apr 24, 2019
BUY
$125.72 - $139.79 $579,317 - $644,152
4,608 Added 1.91%
246,481 $34.5 Million
Q4 2018

Jan 29, 2019
SELL
$122.84 - $147.84 $1.01 Million - $1.21 Million
-8,214 Reduced 3.28%
241,873 $31.2 Million
Q3 2018

Oct 26, 2018
BUY
$121.58 - $142.88 $1.05 Million - $1.23 Million
8,611 Added 3.57%
250,087 $34.6 Million
Q2 2018

Aug 10, 2018
SELL
$119.4 - $131.76 $237,606 - $262,202
-1,990 Reduced 0.82%
241,476 $29.3 Million
Q1 2018

May 01, 2018
SELL
$125.1 - $148.14 $501,025 - $593,300
-4,005 Reduced 1.62%
243,466 $31.2 Million
Q4 2017

Feb 07, 2018
BUY
$131.22 - $143.62 $648,751 - $710,057
4,944 Added 2.04%
247,471 $34.6 Million
Q3 2017

Nov 09, 2017
BUY
$129.47 - $135.38 $31.4 Million - $32.8 Million
242,527
242,527 $31.5 Million

Others Institutions Holding JNJ

# of Institutions
4,270
Shares Held
1.68B
Call Options Held
17.6M
Put Options Held
14.5M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $400B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email